You know how Week 1 immediately divided the user base into two factions, those who regarded opening weekend as its own ...

Zepbound and Trulicity are two U.S. Food and Drug Administration (FDA)-approved medications. When used alongside diet and ...

But right now, is one recent disturbing trend bad news for Lilly in this key growth market? Let's find out. So, first, a bit of background on these pharma companies' portfolios. Novo sells semaglutide ...

Two drugs now generate almost two-thirds of the pharmaceutical giant's revenue.

With the rise of Ozempic and Wegovy, I find myself asking a question I wish I were above asking: Is getting thinner the goal ...

When Laura Patnaude stepped into her wedding gown for her first fitting last month, she asked her seamstress, “How much ...

Consumers should be more circumspect when considering these telehealth sites. They might provide an easier or cheaper avenue ...

The popular obesity drugs are being cavalierly prescribed. It should be yet another wake-up call for regulators. Virtual clinics are popular with patients who have become frustrated by the often ...

Moreover, about 9 in 10 Americans are aware that the drugs are available for weight loss, up from 8 in 10 in 2024. That's ...

The GLP-1 trade has matured from a single-stock story into a tiered opportunity set as demand for obesity therapeutics keeps ...

MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that all enrolled active patients in Part 3 of its Phase 1 clinical trial ...